Sign in
4

Changes in Ownership

Entrada Therapeutics, Inc. Filed Acc 0001689375-25-000029

Options or other derivatives

  • Director acquired 38,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Radhakrishnan Maha Director 2025-06-01 Grant or award · Stock Option (Right to Buy) +38,000 38,000 D
Loading xslF345X05/wk-form4_1748952778.xml…